Yahoo Web Search

Search results

    • Combined General Meeting of June 24, 2024

      Digital Journal· 9 hours ago

      BIO101 (20-hydroxyecdysone), our lead drug candidate, is a small molecule in development for muscular (sarcopenia, phase 3 ready and Duchenne muscular dystrophy< ...